客座编辑评论：了解新型药物时代多发性骨髓瘤的发病机制及不断演变的治疗模式。 - Suppr

Suppr

超能文献

Guest editorial: understanding the pathogenesis and the evolving treatment paradigm for multiple myeloma in the era of novel agents.

作者信息

Abe Masahiro

机构信息

University of Tokushima, Tokushima, Japan.

出版信息

Int J Hematol. 2011 Oct;94(4):307-309. doi: 10.1007/s12185-011-0950-4. Epub 2011 Oct 13.

DOI:10.1007/s12185-011-0950-4

PMID:21993876

Abstract

摘要

相似文献

Guest editorial: understanding the pathogenesis and the evolving treatment paradigm for multiple myeloma in the era of novel agents.客座编辑评论：了解新型药物时代多发性骨髓瘤的发病机制及不断演变的治疗模式。

Int J Hematol. 2011 Oct;94(4):307-309. doi: 10.1007/s12185-011-0950-4. Epub 2011 Oct 13.

[Multiple myeloma. Diagnosis and therapy].[多发性骨髓瘤。诊断与治疗]

Internist (Berl). 2003 May;44(5):599-600, 603-16; quiz 617-8. doi: 10.1007/s00108-003-0920-x.

Current concepts of clinical management of multiple myeloma.多发性骨髓瘤临床管理的当前概念

Dis Mon. 2012 Apr;58(4):195-207. doi: 10.1016/j.disamonth.2012.01.006.

How to Think About Risk in Myeloma.如何看待骨髓瘤中的风险

Clin Lymphoma Myeloma Leuk. 2016 Aug;16 Suppl:S135-8. doi: 10.1016/j.clml.2016.02.015.

[Multiple myeloma].[多发性骨髓瘤]

Praxis (Bern 1994). 2012 Jun 20;101(13):857-61. doi: 10.1024/1661-8157/a000986.

The impact of NF-κB signaling on pathogenesis and current treatment strategies in multiple myeloma.NF-κB 信号通路对多发性骨髓瘤发病机制及现行治疗策略的影响。

Blood Rev. 2019 Mar;34:56-66. doi: 10.1016/j.blre.2018.11.003. Epub 2018 Nov 23.

Myeloma bone disease: pathogenesis and treatment.骨髓瘤骨病：发病机制与治疗

Oncology (Williston Park). 2005 Jul;19(8):983-4, 986.

[Physiopathology, diagnosis and therapy in multiple myeloma (discussion)].多发性骨髓瘤的病理生理学、诊断与治疗（讨论）

Nihon Naika Gakkai Zasshi. 1995 Jul 10;84(7):1132-49.

[Multiple Myeloma].[多发性骨髓瘤]

Gan To Kagaku Ryoho. 2014 May;41(5):580-6.

Multiple myeloma.多发性骨髓瘤

Hematology Am Soc Hematol Educ Program. 2002:214-40. doi: 10.1182/asheducation-2002.1.214.

引用本文的文献

Heme Oxygenase-1 Overexpression Promotes Uveal Melanoma Progression and Is Associated with Poor Clinical Outcomes.血红素加氧酶-1过表达促进葡萄膜黑色素瘤进展并与不良临床预后相关。

Antioxidants (Basel). 2022 Oct 8;11(10):1997. doi: 10.3390/antiox11101997.

Effect of Lipoic Acid on the Biochemical Mechanisms of Resistance to Bortezomib in SH-SY5Y Neuroblastoma Cells.硫辛酸对硼替佐米耐药的 SH-SY5Y 神经母细胞瘤细胞生化机制的影响。

Mol Neurobiol. 2018 Apr;55(4):3344-3350. doi: 10.1007/s12035-017-0575-6. Epub 2017 May 11.

The non-canonical functions of the heme oxygenases.血红素加氧酶的非经典功能。

Oncotarget. 2016 Oct 18;7(42):69075-69086. doi: 10.18632/oncotarget.11923.

Heme oxygenase-1 nuclear translocation regulates bortezomibinduced cytotoxicity and mediates genomic instability in myeloma cells.血红素加氧酶-1的核转位调节硼替佐米诱导的细胞毒性并介导骨髓瘤细胞中的基因组不稳定性。

Oncotarget. 2016 May 17;7(20):28868-80. doi: 10.18632/oncotarget.7563.

本文引用的文献

Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasone.基于基因表达谱的风险分层对接受来那度胺和地塞米松初始治疗的骨髓瘤患者的影响。

Blood. 2011 Oct 20;118(16):4359-62. doi: 10.1182/blood-2011-03-342089. Epub 2011 Aug 22.

Targeting bone as a therapy for myeloma.将骨骼作为骨髓瘤的一种治疗靶点。

Cancer Microenviron. 2011 Dec;4(3):299-311. doi: 10.1007/s12307-011-0079-2. Epub 2011 Aug 11.

The microenvironment and molecular biology of the multiple myeloma tumor.多发性骨髓瘤肿瘤的微环境和分子生物学。

Adv Cancer Res. 2011;110:19-42. doi: 10.1016/B978-0-12-386469-7.00002-5.

Advances in the biology and treatment of bone disease in multiple myeloma.多发性骨髓瘤中骨疾病的生物学和治疗进展。

Clin Cancer Res. 2011 Mar 15;17(6):1278-86. doi: 10.1158/1078-0432.CCR-10-1804.

Shifts in the therapeutic paradigm for patients newly diagnosed with multiple myeloma: maintenance therapy and overall survival.新诊断多发性骨髓瘤患者治疗模式的转变：维持治疗和总生存期。

Clin Cancer Res. 2011 Mar 15;17(6):1253-63. doi: 10.1158/1078-0432.CCR-10-1925.

Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myeloma.沙利度胺、来那度胺和硼替佐米在新诊断多发性骨髓瘤中的治疗作用。

Expert Rev Hematol. 2011 Feb;4(1):51-60. doi: 10.1586/ehm.10.83.

Management of older patients with multiple myeloma.多发性骨髓瘤老年患者的治疗管理。

Blood Rev. 2011 Mar;25(2):65-73. doi: 10.1016/j.blre.2010.10.003. Epub 2011 Feb 4.

International staging system and metaphase cytogenetic abnormalities in the era of gene expression profiling data in multiple myeloma treated with total therapy 2 and 3 protocols.国际分期系统与中期细胞遗传学异常在多发性骨髓瘤治疗中的总治疗 2 和 3 方案和基因表达谱数据时代。

Cancer. 2011 Mar 1;117(5):1001-9. doi: 10.1002/cncr.25535. Epub 2010 Oct 13.

Tumor-host cell interactions in the bone disease of myeloma.骨髓瘤骨病中的肿瘤-宿主细胞相互作用。

Bone. 2011 Jan;48(1):121-8. doi: 10.1016/j.bone.2010.06.029. Epub 2010 Jul 13.

Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients.用于新诊断多发性骨髓瘤患者分子分类的基因表达谱分析。

Blood. 2010 Oct 7;116(14):2543-53. doi: 10.1182/blood-2009-12-261032. Epub 2010 Jun 23.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验